White House pulls Heidi Overton’s nomination to lead the FDA

Must read

The White House said Tuesday it pulled Dr. Heidi Overton’s nomination to lead the Food and Drug Administration after support among Senate Republicans wavered, The Associated Press reported. The agency remains under acting leadership.

President Donald Trump sent Overton’s nomination to the Senate in September. Overton, a physician and White House domestic policy adviser, was nominated to succeed Martin Makary. The Senate health committee’s nominations record shows that it held a hearing on Sept. 24.

AP reported that Senate health committee chair Bill Cassidy, a Louisiana Republican, had raised questions about vaccine policy. Cassidy had previously sought commitments from administration health nominees on maintaining vaccine standards, according to AP.

Kyle Diamantas is the acting commissioner. He took over in May after serving as the agency’s top food official, AP reported. The nomination’s withdrawal leaves the FDA without a Senate-confirmed successor to Makary.

How this article was produced

This article was generated using AI from the sources linked in the article. It was not reviewed by a human before publication and does not include firsthand reporting or interviews. Claims attributed to outside sources have not been independently verified by this publication.

Found an error? Email corrections@thecivicbearing.com.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article